Oppenheimer & Co., Inc.
12
40M
9
0.08
3
0.25
4
- Areas of investment
Summary
Oppenheimer & Co., Inc. is the famous Corporate Investor, which was founded in 1881. The main office of represented Corporate Investor is situated in the New York. The fund was located in North America if to be more exact in United States.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2015. The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2018. This Oppenheimer & Co., Inc. works on 38 percentage points more the average amount of lead investments comparing to the other organizations.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Oppenheimer & Co., Inc., startups are often financed by Magma Venture Partners, Goldman Sachs, VantagePoint Capital Partners. The meaningful sponsors for the fund in investment in the same round are Wit SoundView Ventures, VantagePoint Capital Partners, Scudder Technology Fund. In the next rounds fund is usually obtained by VantagePoint Capital Partners, Stata Venture Partners, Prism Venture Management.
Among the most popular portfolio startups of the fund, we may highlight Wananchi Group, Intec Pharma. The fund has no specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel. Among the most successful fund investment fields, there are Internet, Pharmaceutical.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 3
- Exits
- 4
- Rounds per year
- 0.08
- Follow on index
- 0.25
- Investments by industry
- Health Care (3)
- Telecommunications (3)
- Media and Entertainment (3)
- Self-Storage (2)
- Consumer (2) Show 18 more
- Investments by region
-
- Israel (3)
- United States (4)
- United Kingdom (2)
- Kenya (1)
- Canada (1) Show 1 more
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Group Appearance index
- 0.67
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Perspectum | 15 Mar 2023 | Health Care, Wellness, Medical Device, Medical | Late Stage Venture | 19M | England, Oxford, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.